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Living kidney donors’ follow‑up is usually focused on the assessment of the surgical and medical 
outcomes. Whilst the psychosocial follow‑up is advocated in literature. It is still not entirely clear 
which exact psychosocial factors are related to a poor psychosocial outcome of donors. The aim of 
our study is to prospectively assess the donors’ psychosocial risks factors to impaired health‑related 
quality of life at 1‑year post‑donation and link their psychosocial profile before donation with their 
respective outcomes. The influence of the recipient’s medical outcomes on their donor’s psychosocial 
outcome was also examined. Sixty donors completed a battery of standardized psychometric 
instruments (quality of life, mental health, coping strategies, personality, socio‑economic status), and 
ad hoc items regarding the donation process (e.g., motivations for donation, decision‑making, risk 
assessment, and donor‑recipient relationship). Donors’ 1‑year psychosocial follow‑up was favorable 
and comparable with the general population. So far, cluster‑analysis identified a subgroup of donors 
(28%) with a post‑donation reduction of their health‑related quality of life. This subgroup expressed 
comparatively to the rest, the need for more pre‑donation information regarding surgery risks, and 
elevated fear of losing the recipient and commitment to stop their suffering.
Living kidney donor transplantation (LKDT) represents around the 40% of the overall transplantation  activity1,2 
and is the best treatment currently available for patients with end-stage renal disease. However, the recipient’s 
benefits must be balanced against potential negative short and long-term physical and psychosocial consequences 
for living kidney donors (LKDs)3,4.
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LKDs follow-up is usually focused on the assessment of surgical and medical outcomes, including physical 
risks. Whilst the psychosocial follow-up is advocated in literature, it remains poorly standardized, and mainly 
based on cross-sectional studies. Hence, LKDs post-donation psychosocial outcome is still an open  topic5–8. A 
more detailed understanding of the potential psychosocial benefits and harms of LKDT is critical to improve 
the informed consent process and to guarantee the security of the donation  process3,9.
Available studies on LKDs psychosocial outcomes are commonly retrospective, include single centers with 
small sample sizes, and are usually based on professional opinions and experiences instead of standardized ques-
tionnaires. Therefore, their conclusions might be  limited10. In spite of recent publications, prospective studies 
about psychosocial outcomes of donation remains poorly  understood9,11–15. The results obtained so far suggest 
that the majority of donors recall the donation experience as a worthy  undertaking12. However, a small propor-
tion of LKDs report adverse psychosocial and emotional outcomes, mainly depression, anxiety, fatigue, marital 
stress, and economic  costs3,15–17. No matter how small the group of LKDs suffering adverse psychosocial outcomes 
might be, these findings show some room for improvement in current practices. For instance, there is a wide 
heterogeneity among the transplant centers and a lack of consensus concerning methodology, professionals, 
instruments, and the most appropriate time to perform the psychosocial pre-donation evaluation and follow-
up8,18–22. Therefore, both the Transplant Community and International Societies recognize either the importance 
of replicating the results of prospective and retrospective studies, or of promoting additional ones.
A more precise definition of these risk factors might guide the implementation of interventions to prevent 
negative consequences and thus the improvement of the information provided to potential donors during the 
pre-donation  assessment12,21–25.
This background prompted the design of the European Living Donor Psychosocial Follow-Up (ELIPSY) 
project, which was a multi-center international research co-funded by the Executive Agency for Health and 
Consumers grant agreement 20081104. The ELIPSY project aimed to examine the psychosocial outcome and 
the impact of the donation process on LKDs ensuring a high quality of LKDT  programs19. One of the ELIPSY 
project’s branches aimed to prospectively assess the LKDs health-related quality of life (HRQoL) outcome at 
1-year post-donation; with the goal of linking their psychosocial profile prior to donation (quality of life, mental 
health, coping strategies, personality, socio-economic status, psychiatric history, motivations for donation, deci-
sion making, and risk assessment) with their respective psychosocial outcome (quality of life, mental health, 
coping strategies, socio-economic status, life events, donor-recipient relationship, and perception of the recipi-
ent’s health). The influence of the recipient’s outcome on their LKDs HRQoL was also included in the study.
According to previous authors, we expected that LKDs with a post-donation reduction of their HRQoL would 
be those who had an impaired post-donation physical  health11,15,26, higher depression and anxiety  levels11,27 and 
lowest dispositional  optimism28. Regarding recipients’ characteristics, we hypothesize that those LKD´s with 
recipients with poor medical outcomes will report a higher incidence of HRQoL  reduction11,29.
Results
Participants. Seventy-five LKDs were included at pre-donation. All donors were genetically or emotionally 
related with their recipient. The range of LKDs participation was comparable between centers, the percentages 
varied from 26.3 to 34.9%. Sixty-four (85.3%) LKDs completed the post-donation follow-up while 11 (14.7%) 
were lost during the follow-up. At post-donation, four LKDs out of the 64 were excluded, due to missing values 




LKDs with pre and post-donaon assessment
n = 64
Final sample n = 60
Excluded: 4
Incomplete survey: missing values in relevant 
variables 
Dropout: 11 LKDs (14.7%)
LKDs only with pre-donaon assessment 
Figure 1.  Participants flowchart.
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Principal component analysis of motivations for donation. Table 1 shows that 26 out of 31 items 
assessed by Likert scale were included in the analysis. Every item produced a range of responses from 1 (not 
relevant) to 5 (very important).
The main component analysis with varimax rotation led to the extraction of four-factors, accounting for 53.7% 
of the variance in the item-set. Factors accounted for 15.6%, 14.2%, 12.4%, and 11.5% of variance respectively. 
Five items (#113, #115, #120, #127 and #134) did not contribute to the factors definition and thus were excluded.
Factor 1 included nine items assessing LKDs’ personal responsibility, and obligation. Factor 2 included 10 
items describing the donors’ fear of losing the recipient/commitment to stop their suffering/save their lives. Factor 
3 included six items measuring LKDs’ fears and concerns about donations’ own consequences and family and 
friends’ opinion; including the lifelong consequences of donating a kidney. Factor 4 included six items assessing 
the expectations/goals to fulfill with the donation decision; covering personal growth, interpersonal benefits, and 
the financial implications of donation. Five items (#124, #125, #130, #131 and #141) showed positive high-loads 
in two factors. Therefore, these items were included in both factors.
Internal consistency was: Alpha for Factor 1 = 0.84; Factor 2 = 0.82; Factor 3 = 0.79; Factor 4 = 0.78.
Randomness of attrition. Differences between completers (60) and LKDs lost to follow-up (11) for donor 
and recipient characteristics were analyzed. Completers showed lower levels of depression and higher scores in 
the EPQ-RA extraversion scale. Concerning the recipients’ characteristics, Diabetes Mellitus as indication for 
kidney transplantation was significantly less frequent in the completers group.
Pre‑donation characteristics. Table 2 describes the completers and their recipients’ baseline characteris-
tics. Most completers were women (60.0%), with a mean (SD) age of 50.2 (11.7) years at donation, the majority 
had a partner (63.3%), and were genetically related with their recipient (53.3%).
LKDs’ baseline of SF-36 T-scores was in the average of the general population on all eight dimensions (scale 
0–100). Only 11 donors (18.6%) had seen a psychiatrist or psychologist before.
In relation to the decision-making process, most of the LKDs (60.3%) did not consider it was necessary to 
take time to think over the donation and concerns to risk assessment, and the majority (89.8%) did not need 
more information regarding the surgery and its risks.
Table 1.  Principal component analysis of motivations for donation. Bold values are the items cross-loaded in 
each factor. † Likert scale for all the items from 1 (not relevant) to 5 (very important).
Items†
Factor
1 2 3 4
114—Fear that giving up my kidney might shorten my life span 0.030 0.244 0.663 0.227
116—Fear that giving up my kidney might damage my health or cause me problems in the future  − 0.043 0.201 0.769 0.070
117—Concern that some of my family or friends disapprove of my donating my kidney 0.223  − 0.262 0.786 0.186
118—Concern that some of my family or friends would disapprove of my decision not to donate 0.291  − 0.251 0.717 0.227
119—Wish to feel closer to the person that I was donating my kidney 0.090 0.191 0.166 0.663
121—Concern about having a scar  − 0.140 0.148 0.605  − 0.129
122—Concern about financial implications of donating my kidney  − 0.243  − 0.224 0.223 0.553
123—Feeling that this was a unique opportunity to do something very special 0.161 0.127  − 0.093 0.727
124—Wish to feel that I am a good person 0.430  − 0.008 0.061 0.721
125—Worry that the person I was donating my kidney to might not take care of it properly 0.479 0.155 0.639  − 0.044
126—I didn’t want to lose the recipient, I am afraid he/she will die if I do not donate 0.025 0.724 0.063 0.039
128—I am unable to watch the recipient suffer and not do anything about it 0.067 0.570  − 0.024  − 0.025
129—It is a personal challenge/test for me 0.212 0.279 0.130 0.635
130—Wish to show my deep love and respect to the recipient 0.021 0.517 0.073 0.557
131—Feeling responsible for the recipient 0.400 0.508 0.074 0.244
132—Feeling I owe that to the recipient 0.755 0.173 0.027 0.184
133—Wish not to disappoint the recipient 0.680 0.135 0.036 0.117
135—In past situations, I did not have the chance to influence things. Now I do and I want to use 
this chance  − 0.100 0.464 0.239 0.091
136—The recipient is too young to suffer/die and deserves to live further 0.247 0.488 0.099  − 0.281
137—Feeling obligated as a person/relative to do that 0.827 0.114  − 0.071 0.030
138—Feeling of being responsible as a family member to do that 0.793 0.031 0.063 0.097
139—I am the only donor available 0.337 0.646 0.016 0.234
140—I am the most suitable donor 0.330 0.471 0.093 0.168
141—There is no other choice 0.452 0.630  − 0.058 0.045
142—The family thought/decided that I would be the most suitable to donate 0.590 0.087 0.252 0.029
143—It just makes sense for me to donate 0.004 0.551 0.005 0.162
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All partici-pants (n = 60) Cluster 1 (n = 43) Cluster 2 (n = 17)
t/x2 p
Univariate logistic regression 
p§Mean (sd)/n (%) Mean (sd)/n (%) Mean (sd)/n (%)
Socio-demographic characteristics
Age (years) 50.18 (11.73) 51.41 (11.40) 47.05 (12.31) 1.306 0.197 0.191
Gender (female) 36 (60.0%) 25 (58.1%) 11 (64.7%) 0.219 0.640 0.638
Donor-recipient relationship (genetically related) 32 (53.3%) 24 (55.8%) 8 (47.1%) 0.375 0.540 0.541
Marital status
Without partner (single, divorced, widowed) 22 (36.7%) 14 (32.6%) 8 (47.1%) 1.140 0.565 0.298
With partner 38 (63.3%) 29 (67.4%) 9 (52.9%)
Level of studies
No academic, elementary 19 (32.2%) 13 (31.0%) 6 (35.3%) 0.104 0.747 0.748
Intermediate 22 (37.3%) 15 (35.7%) 7 (41.2%) 0.154 0.694 0.695
Upper studies 18 (30.5%) 14 (33.3%) 4 (23.5%) 0.549 0.545† 0.452
Psychometric instruments
Quality of life
Anamnestic comparative self-assessment, range − 5 
(worst period) to 5 (best period) 2.79 (1.74) 2.59 (1.85) 3.29 (1.33)  − 1.335 0.188 0.158
Item short form survey (SF-36), range 0–100¶
Physical functioning (PF) 53.87 (5.45) 55.09 (3.35) 50.78 (8.12) 2.119‡ 0.048
Role physical (RP) 55.09 (3.01) 55.02 (3.29) 55.26 (2.21)  − 0.283 0.778
Bodily pain (BP) 58.43 (5.28) 58.69 (4.59) 57.78 (6.85) 0.504‡ 0.619
General health (GH) 56.28 (7.01) 57.05 (6.34) 54.32 (8.36) 1.216‡ 0.236
Vitality (VT) 58.00 (7.47) 57.40 (7.81) 59.54 (6.51)  − 0.999 0.322
Social functioning (SF) 54.90 (4.83) 54.72(5.45) 55.36 (2.77)  − 0.459 0.648
Role emotional (RE) 54.60 (3.64) 54.37 (4.24) 55.17 (1.04)  − 0.762 0.449
Mental health (MH) 55.48 (6.58) 54.40 (6.94) 58.21 (4.71)  − 2.078 0.042
Mental health status
Hospital anxiety and depression scale
Anxiety scale, range 0–21 3.70 (2.84) 3.91 (2.88) 3.18 (2.74) 0.892 0.376 0.358
Depression scale, range 0–21 1.75 (1.94) 1.93 (2.04) 1.29 (1.65) 1.146 0.257 0.231
Coping strategies
Optimism, life orientation test-revised (sum of items) 
range 6–30 23.90 (4.44) 24.14 (4.58) 23.29 (4.17) 0.661 0.511 0.508
Sense of coherence, range 1–7 5.55 (0.94) 5.56 (0.90) 5.52 (1.07) 0.146 0.885 0.882
Personality
Eysenck personality questionnaire-revised-abbreviated
Neuroticism scale, range 0–6 0.98 (1.20) 1.00 (1.25) 0.94 (1.06) 0.177 0.860 0.857
Extraversion scale, range 0–6 4.10 (1.76) 4.14 (1.78) 4.00 (1.79) 0.273 0.786 0.782
Psychoticism scale, range 0–6 1.41 (1.07) 1.33 (1.11) 1.63 (0.96)  − 0.956 0.343 0.334
Socioeconomic status
English longitudinal study of ageing range 1 (worst off) to 10 (best off)
Socioeconomic status range 1 (worst off) to 10 (best 
off) 6.31 (1.43) 6.35 (1.42) 6.20 (1.47) 0.345 0.732 0.726
Ad hoc items
Psychiatric history
Have you ever seen a counselor, psychiatrist or psy-
chologist? (yes) 11 (18.6%) 10 (23.3%) 1 (6.3%) 2.223 0.259
† 0.104
Motivations/reasons for donation
Personal responsibility and obligation (mean of items) 
range 1 (not relevant) to 5 (very important) 2.07 (0.89) 1.92 (0.77) 2.47 (1.07)  − 2.081 0.043 0.046
Donors’ desire to stop their recipients’ suffering and/or 
save their lives (mean of items) range 1 (not relevant) 
to 5 (very important)
3.40 (0.90) 3.27 (0.87) 3.87 (0.83)  − 2.313 0.025 0.022
Donors’ fears and concerns about donation’s own 
consequences and family and friends opinion (mean of 
items) range 1 (not relevant) to 5 (very important)
1.33 (0.55) 1.27 (0.46) 1.47 (0.71)  − 1.229 0.224 0.236
Challenges involving the donation decision; including 
personal growth and financial implications (mean of 
items) Range 1 (not relevant) to 5 (very important)
2.42 (0.99) 2.33 (1.03) 2.64 (0.86)  − 1.040 0.303 0.297
Decision making
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The recipients’ most frequent indication for transplantation was glomerulopathy (29.3%); the majority was 
registered in a waiting list for deceased donor (60.4%) and was on dialysis before transplantation (67.2%).
Post‑donation outcomes. Table 3 shows the post-donation outcomes of LKDs and their recipients. At 
post-donation, mental health remained stable for the majority of donors. Few adverse psychosocial outcomes 
were observed; regarding their employment situation, only one donor (1.8%) reported being unemployed 
because of donation. The donor-recipient relationship had deteriorated in one case (1.7%) and only one donor 
(1.7%) required psychological/psychiatric treatment after donation. However, nearly a quarter (22.4%) of the 
LKDs self-reported physical complications related with the donation (e.g. scars, pain, etc.).
The recipient and graft survival at 1-year was 98.3% and 94.9% respectively. Two (3.5%) recipients had 
unexpectedly bad kidney function (glomerular filtration rate below 30 mL/min) at 1-year. The reported serum 
creatinine was within the expected ranges (131.7 (98.3) µmol/L).
Comparison between pre and post‑donation. Table 4 shows the comparative results between pre and 
post-donation assessments. SF-36 T-scores worsened at post-donation on: limitations due to physical problems 
(role physical), pain and the effect of pain on activities (bodily pain), and the feeling of energy (vitality). HADS 
depression dimension showed a statistically significant decrement at post-donation. ELSA subjective socioeco-
nomic status reported a small, but statistically significant, post-donation improvement.
Cluster‑analyses. The two-step cluster-analysis suggested two subgroups of LKDs: cluster 1 (n = 43, 71.7%) 
reported no change in their HRQoL, and cluster 2 (n = 17, 28.3%) reported a post-donation worsening of their 
HRQoL. Percentages of change between clusters are shown in Fig. 2. Donors from cluster 2 were characterized 
by a statistically significant decrement on five of the eight scales of SF-36: limitations due to physical problems 
(role physical), pain and the effect of pain on daily activities (bodily pain), the energy (vitality), limitations due 
to emotional problems (role emotional), and psychological distress and well-being (general mental health).
Cross‑sectional comparisons between clusters. At pre-donation, donors from cluster 1 and 2 were 
similar in most socio-demographic and clinical characteristics. However, cluster 2 was characterized by a higher 
motivation to donate because of feeling responsible as recipient’s relative and/or feeling that there was no other 
Table 2.  Pre-donation characteristics and differences between clusters. † Fisher’s exact test. ‡ Not assuming 
equality of variances. § Any p-value remained statistically significant after FDR correction. ¶ SF-36 T scores (> 55 
is higher than average, < 45 is lower than average).
All partici-pants (n = 60) Cluster 1 (n = 43) Cluster 2 (n = 17)
t/x2 p
Univariate logistic regression 
p§Mean (sd)/n (%) Mean (sd)/n (%) Mean (sd)/n (%)
Strongly disagree/Disagree 35 (60.3%) 26 (63.4%) 9 (52.9%) 0.551 0.458 0.460
Agree/strongly agree 23 (39.7%) 15 (36.6%) 8 (47.1%)
Risk assessment
Necessity of more information regarding the surgery 
and its risks (yes) 6 (10.2%) 2 (4.8%) 4 (23.5%) 4.667 0.097 0.041
Recipients’ characteristics
Recipients’ socio-demographic characteristics
Weight (Kg) 77.64 (19.07) 79.37 (20.33) 73.09 (14.89) 1.122 0.267 0.256
Recipient baseline
African ancestry (yes) 2 (3.4%) 1 (2.4%) 1 (5.9%) 0.453 0.497† 0.521
Indication of transplantation
Urological 4 (6.9%) 4 (9.5%) 0 (0%) 1.637 0.567†
Glomerulopathy 17 (29.3%) 14 (33.4%) 3 (18.8%) 1.189 0.347†
Nephroangioesclerosis 7 (12.1%) 4 (9.5%) 3 (18.7%) 0.929 0.381†
Diabetes Mellitus 2 (3.4%) 0 (0%) 2 (12.5%) 5.438 0.073†
Others 8 (13.8%) 6 (14.3%) 2 (12.5%) 0.031 1.000†
Unknown 12 (20.7%) 10 (23.8%) 2 (12.5%) 0.903 0.479†
Polycystic kidney disease 8 (13.8%) 4 (9.5%) 4 (25.0%) 2.334 0.198†
Registration in waiting list for deceased donor (yes) 35 (60.4%) 22 (53.7%) 13 (76.5%) 2.613 0.144† 0.098
Dialysis before transplantation (yes) 39 (67.2%) 27 (65.9%) 12 (70.6%) 0.122 0.727 0.725
Previous kidney transplantation (yes) 6 (10.3%) 5 (12.2%) 1 (5.9%) 0.516 0.660† 0.451
Previous other organ transplantation (yes) 0 (0%) 0 (0%) 0 (0%)
High immunological risk (yes) 11 (19.6%) 7 (17.1%) 4 (26.7%) 0.640 0.461† 0.434
High risk of recurrence (yes) 4 (7.0%) 3 (7.3%) 1 (6.3%) 0.020 1.000† 0.886
Presence of serious co-morbid diseases (yes) 11 (19.3%) 8 (19.5%) 3 (18.8%) 0.004 1.000† 0.948
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All partici-pants (n = 60) Cluster 1 (n = 43) Cluster 2 (n = 17)
t/x2 pMean (SD)/n (%) Mean (SD)/n (%) Mean (SD)/n (%)
Elapsed time between donation and donors’ follow-up (months) 12.78 (3.44) 13.34 (3.44) 11.36 (3.12) 2.069 0.043
Psychometric instruments
Quality of life
Anamnestic comparative self-assessment, range − 5 (worst period) to 5 (best period) 2.77 (1.79) 3.07 (1,68) 1.98 (1.88) 2.157 0.035
36-item short form survey (SF-36) range 0–100§
Physical functioning (PF) 52.79 (7.32) 55.54 (3.04) 45.84 (10.10) 3.890‡ 0.001
Role Physical (RP) 53.13 (7.31) 55.37 (2.24) 47.45 (11.67) 2.779‡ 0.013
Bodily pain (BP) 54.46 (8.76) 58.84 (4.00) 43.36 (7.66) 7.915‡  < 0.001
General health (GH) 54.71 (8.53) 57.50 (7.22) 47.64 (7.61) 4.695  < 0.001
Vitality (VT) 54.51 (7.89) 56.31 (7.24) 49.98 (7.82) 2.985 0.004
Social functioning (SF) 54.37 (4.70) 55.35 (3.72) 51.88 (6.01) 2.215‡ 0.038
Role emotional (RE) 52.63 (7.32) 54.18 (4.47) 48.70 (11.05) 1.982‡ 0.063
Mental health (MH) 54.30 (6.48) 55.90 (4.71) 50.28 (8.54) 2.563‡ 0.019
Mental health status
Hospital anxiety and depression scale
Anxiety scale, range 0–21 3.73 (3.18) 3.11 (2.97) 5.24 (3.25)  − 2.412 0.019
Depression scale, range 0–21 1.17 (1.75) 0.85 (1.33) 1.94 (2.36)  − 1.787‡ 0.089
Coping strategies
Sense of coherence, range 1–7 5.63 (0.84) 5.72 (0.83) 5.40 (0.83) 1.366 0.177
Social support
English longitudinal study of ageing
Socioeconomic status range 1 (worst off) to 10 (best off) 6.64 (1.54) 6.70 (1.46) 6.47 (1.81) 0.497 0.621
Ad hoc items
Quality of life
Suffered complaints or illnesses because of the donation (Yes) 13 (22.4%) 3 (7.3%) 10 (58.8%) 18.333  < 0.001
Current physical condition affected by the donation. range 0 (nothing) to 10 (a lot) 1.84 (2.67) 1.44 (2.63) 2.88 (2.58)  − 1.864 0.068
The post-operative recovery was:
More difficult than I had imagined 14 (24.1%) 7 (17.1%) 7 (41.2%) 3.813 0.051
Easier than I had imagined 29 (50.0%) 20 (48.8%) 9 (52.9%) 0.083 0.773
Exactly as I had imagined 14 (24.1%) 13 (31.7%) 1 (5.9%) 4.377 0.046†
I don’t know/I don’t remember 1 (1.8%) 1 (2.4%) 0 (0%) 0.422 1.000†
Mental health
Necessity of psychological/psychiatric treatment or counseling since the donation
No 57 (95.0%) 40 (93.0%) 17 (100%) 1.248 0.551†
Yes 2 (3.3%) 2(4.7%) 0 (0%) 0.818 1.000†
Yes, because of the donation 1 (1.7%) 1 (2.3%) 0 (0%) 0.401 1.000†
Current emotional condition affected by the donation. range 0 (nothing) to 10 (a lot) 1.75 (2.84) 1.40 (2.69) 2.65 (3.01)  − 1.555 0.126
After surgery I felt forgotten (true) 7 (11.7%) 3 (7.0%) 4 (23.5%) 3.239 0.092†
Somehow I feel worried about my health since the donation (true) 5 (8.5%) 1 (2.4%) 4 (25.5%) 6.978 0.021†
The recipient’s health still occupies me a lot (true) 46 (78.0%) 32 (76.2%) 14 (82.4%) 0.268 0.738†
Socio-economic status
Did you suffer any financial loss due to the donation? (Yes) 20 (33.3%) 15 (34.9%) 5 (29.4%) 0.164 0.685
Life events
Did you experience any other life changing events since donation? (yes) 13 (22.0%) 10 (23.3%) 3 (18.8%) 0.138 1.000†
Intensity of distress for life events (Mean of items) Range 0 (no distress at all) to 10 (the 
worst experience) 4.23 (5.3) 4.12 (5.5) 4.7 (4.6)  − 0.265 0.792
Donor-recipient relationship
Do you feel your relationship to the recipient has changed after the donation? (yes) 19 (31.7%) 14 (32.6%) 5 (29.4%) 0.056 0.813
Have you been in charge of the recipient since the donation? (yes) 18 (31.6%) 13 (30.2%) 5 (35.7%) 0.147 0.702
Perception of the recipient’s health after transplantation
The recipient enjoys good health currently
Strongly disagree/disagree 5 (8.5%) 2 (4.7%) 3 (18.8%) 2.988 0.118†
Agree/strongly agree 54 (91.5%) 45 (95.3%) 13 (81.2%)
The recipient of my organ behaves in a way that risks the continued healthy functioning of the donated kidney
Strongly disagree/disagree 54 (93.1%) 38 (90.5%) 16 (100%) 1.637 0.567†
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choice, because of fear of losing the recipient and emotional commitment to stop their suffering/safe their lives, 
and a higher necessity of more information regarding the surgery and its risks (Table 2).
At post-donation, cluster 2 was characterized by: shorter elapsed time from donation to post-assessment, 
a lower QoL using ACSA, and higher scores on HADS anxiety dimension. In addition, a higher proportion of 
LKDs in cluster 2 reported to still suffering complaints and/or illnesses due to donation, considered the post-
operative recovery more difficult than they expected and a higher proportion of donors’ feel worried about their 
health since the donation. The two recipients with permanent damage in organ function were related to donors 
in cluster 2 (Table 3).
Model of pre‑donation assessment. The univariate logistic regressions for each independent variable 
showed that 12 potential predictive factors reached the level of statistical significance below the 0.30 required 
as screening criterion. These factors included socio-demographic characteristics (age and marital status), QoL 
and mental health status (ACSA and HADS depression dimension), psychiatric history, the four motivations 
for donation, risk assessment (necessity of more information regarding the surgery and its risks), and recipient 
characteristics (recipients’ weight and waiting list registration for deceased donor). Table 2 shows the results of 
the univariate logistic regression.
Table 3.  Post-donation characteristics and differences between clusters. † Fisher’s exact test. ‡ Not assuming 
equality of variances. § SF-36 T scores (> 55 is higher than average, < 45 is lower than average).
All partici-pants (n = 60) Cluster 1 (n = 43) Cluster 2 (n = 17)
t/x2 pMean (SD)/n (%) Mean (SD)/n (%) Mean (SD)/n (%)
Recipients’ post-transplant complications
Permanent damage in organ function (yes) 2 (3.5%) 0 (0%) 2 (11.7%) 4.996 0.082†
Inpatient hospitalization or Prolongation of hospitalization (yes) 21 (36.2%) 14 (33.3%) 7 (43.8%) 0.544 0.461
Permanent or temporary discapacity not requiring hospitalization (yes) 7 (13.0%) 5 (11.9%) 2 (16.7%) 0.188 0.645†
Treatment non-adherence (yes) n:48 1 (2.1%) 1 (2.8%) 0 (0%) 0.340 1.000†
Psychological complications requiring treatment (yes) n:39 1 (2.6%) 0 (0%) 1 (12.5%) 3.977 0.205†
Serum creatinine (Units) 131.7 (98.3) 122.4 (42.0) 157.7 (180.2)  − 0.753‡ 0.464
Recipient survival (yes) 58 (98.3%) 41 (97.6%) 17 (100%) 0.412 1.000†
Graft survival (yes) 56 (94.9%) 41 (97.6%) 15 (88.2%) 2.208 0.197†
Table 4.  Differences between pre-donation and post-donation assessment. † SF-36 T scores (> 55 is higher than 








(SD) Difference t p
Quality of life
ACSA range − 5 (worst period) to 5 (best period) n:51 2.75 (1.73) 2.74 (1.84) 0.01 (2.27) 0.049 0.961
36-item short form survey (SF-36), range 0–100†
Physical functioning (PF) 53.87 (5.45) 52.79 (7.32) 1.08 (6.94) 1.208 0.232
Role physical (RP) 55.09 (3.01) 53.13 (7.31) 1.96 (7.29) 2.084 0.041
Bodily pain (BP) 58.43 (5.28) 54.46 (8.76) 3.97 (8.64) 3.560 0.001
General health (GH) 56.28 (7.01) 54.71 (8.53) 1.57 (8.73) 1.395 0.168
Vitality (VT) 58.00 (7.47) 54.51 (7.89) 3.49 (7.77) 3.479 0.001
Social functioning (SF) 54.90 (4.83) 54.37 (4.70) 0.53 (6.63) 0.621 0.537
Role emotional (RE) 54.60 (3.64) 52.63 (7.32) 1.97 (7.91) 1.926 0.059
Mental health (MH) 55.48 (6.58) 54.30 (6.48) 1.18 (7.89) 1.155 0.253
Mental health status
Hospital anxiety and depression scale
Anxiety scale 3.68 (2.78) 3.80 (3.17)  − 0.11 (3.17)  − 0.272 0.787
Depression scale 1.76 (1.96) 1.19 (1.76) 0.56(2.05) 2.076 0.042
Coping strategies
Sense of coherence, range 1–7 5.55 (0.94) 5.63 (0.84)  − 0.08 (0.61)  − 1.026 0.309
Social support
English longitudinal study of ageing
Socioeconomic status, range 1 (worst off) to 10 (best off) n:53 6.30 (1.42) 6.77 (1.50)  − 0.47 (1.38)  − 2.486 0.016
8
Vol:.(1234567890)
Scientific Reports |        (2020) 10:21343  | https://doi.org/10.1038/s41598-020-78032-8
www.nature.com/scientificreports/
All these potential predictive factors were assessed by multivariate logistic regression. Results showed that the 
pre-donation profile of the LKDs showing a decrease of their HRQoL after donation (Cluster 2) was characterized 
by the feeling of needing more information regarding the surgery and its risks, and by donating because of fear of 
losing the recipient/commitment to stop their suffering/safe their lives (Table 5). The sample size was reduced to 
59 donors, due to one participant had a missing value on the measure “Fear of losing the recipient/commitment 
to stop their suffering/save lives”. As there was only one LKD, we decided to not make any kind of imputation.
The final pre-donation model with only these two predictors and a modified cut-point of the estimated prob-
ability to 0.33 showed a good overall percentage of correct classifications (75.0%), with acceptable sensitivity 
(69.2%) and specificity (77.1%). The AUC = 79.7% (CI 95% 65.0–89.5%) was good, and the shrinkage was very 
low when compared with the AUC obtained with bootstrap estimation (AUC bootstrap = 78.5%). The feeling of 
needing more information (yes/no) regarding the surgery and its risks, multiplied by 8.5 the risk of belonging to 
cluster 2; compared to those donors who did not need additional information about the surgery process; while 
every unit increased (range 1–5) the perception of donor’s fear of losing the recipient/commitment to stop their 
suffering/save their lives as motivation for donation multiplied by 2.7 the risk of presenting a cluster 2 outcome.
Discussion
As previously observed, our results suggest that taken as a whole, LKDs’ psychosocial status remains stable after 
 donation3,9,30,31. Very few post-donation adverse psychosocial outcomes were observed. However, a subgroup 
of donors, characterized by needing more information regarding surgery risks, and those who donated because 
the fear of losing the recipient/commitment for stopping their suffering, suffered a slight deterioration of some 
aspects of their HRQoL. Both variables seem amenable to modification during the donor selection process.
Previous studies have reported that 10–31% of LKDs believe that more information about donation should 
have been provided pre-operatively16,32. The perception of being poorly informed pre-donation has been proposed 
as a determinant of post-donation donor dissatisfaction, especially when the information received pre-donation 
and the donors’ actual experiences highly  diverge33. The perception of needing more information regarding the 
surgery and its risks should be carefully examined to answer all the potential LKDs’ doubts, and ensure they 
feel ready for donation. Furthermore, the necessity of more information might be due to inadequate informa-
tion, but in some cases, it could also be an expression of ambivalence towards donation. This clinical attitude, 
intended to assure legitimacy of the informed consent process, should also include the disclosure of any risks 
newly recognized in the  literature15.
It has already been described that the LKDs’ strongest motive to donate is the desire to improve and/or 
save their recipients’  life34. However, LKDs might not consider some variables related to their recipients’ post-
donation behaviors, such as non-adherence to treatment or consuming excessive alcohol, which fall out of their 
control. These post-donation issues might worsen their experience of donation by causing disappointment or 
even deterioration of the donor-recipient  relationship35. Moreover, a donation mainly motivated by the perceived 
need of saving their recipients’ life may influence LKDs’ decision-making process by speeding up the donation 
 procedure36. Similarly, feelings of obligation and being mainly responsible for the recipients’ health can entail 
aspects of pressure and coercion (e.g. by family) and compromise the autonomy of the donors’ decision and thus 
Figure 2.  Percentage of change in the SF-36 by clusters. PF physical functioning, RP role physical, BP body 
pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health.
Table 5.  Logistic regression for the model of pre-donation assessment (n = 59)†. † One donor had a missing 
value on Fear of losing the recipient/commitment to stop their suffering/save lives.
B S.E Wald df p
Exp (B)
(95% CI)
Necessity of more information regarding the surgery and its risks 2.157 1.001 4.643 1 0.031 8.467 (1.215 61.532)
Fear of losing the recipient/commitment to stop their suffering/save lives 1.009 0.451 5.009 1 0.025 2.743 (1.134 6.638)
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their post-operative psychosocial outcome. These scenarios might have caused the donor to feel not ready for 
donation. Both prompt identification of a prevailing, urgent, and unjustified need to save the recipients’ life, and 
exploration and resolution of the actual recipients’ vital risk (e.g., by discussing alternative interventions such as 
dialysis) might help to ameliorate this risk factor. Additional research regarding LKDs’ motivation to donate is 
needed to replicate our factor solution; we considered that the motivations questionnaire is an interesting tool 
that could be useful in future studies.
Subjective socioeconomic status reported a post-donation small, but statistically significant, post-donation 
improvement. This improvement might be related to the amelioration of their recipients’ physical health. For 
example, two-thirds of our recipients were on dialysis before transplantation. After transplantation, considering 
that all our donors were genetically or emotionally related, both the recipient and the donor would be released 
from the out of pocket expenses caused by the dialysis treatment, and the recipient might restart a full working 
life, which could also have a positive effect on the donors’ socioeconomic status. Although our study did not 
measure changes in working status, a recent study shows that the percentage of recipients who were back to work 
1-year after transplantation depends on the type of  work37. Additional research is needed both to confirm the 
improvement in socioeconomic status and to define its determinants.
The comparison between pre and post-donation HRQoL showed a statistical significance on the reduction 
of three scales of the SF-36. Two of them, measuring the physical component: role physical (the extent to which 
physical health interferes with work or other daily activities) and bodily pain (intensity of pain and its effect on 
activities). The last one, vitality, indicates a decline in energy and an increase in fatigue, which has been normally 
associated to the mental component of HRQoL, but surely, it also affects the physical component. Vitality scores 
could remain somewhat lower in the long-term, the declination of vitality scores requires further investigation 
to define if it is a consequence of donation or a combination of multiple  factors30, and if it is the mostly affected 
component of HRQoL affected by  donation15. It is important to highlight, that these reduction was clinically 
relevant only on bodily pain scale, which was outside of the normal range for the general population.
A higher proportion of donors with HRQoL decrement reported an increased risk of impaired post-donation 
physical health (still suffering complaints and/or illnesses due to donation and considered the post-operative 
recovery more difficult than they expected). Donors’ physical complications and the experience with a long 
recovery time have been associated with impaired function and well-being many years after  donation26. During 
the first year post-donation, the LKDs perform a narrower medical follow-up for the prompt identification of 
medical and psychosocial complications; nonetheless, LKDs with HRQoL decrement feel worried about their 
health, in a higher percentage since the donation.
Contrary to our expectations, no association between recipients’ medical characteristics (pre and post-
transplantation) and donors’ psychosocial outcomes were found. Previous studies have shown that recipients’ 
outcomes may influence donors’ QoL and mental health. However, their results are contradictory, showing 
either an adverse  influence11,29,36, or no association between medical complications of recipients and donors’ 
psychosocial  outcomes26,31,38. A closer monitoring of donors with high-risk recipients at pre-donation (e.g. 
hyperimmunized patients) or with perioperative complications (e.g. bleedings, hematomas, and wound infec-
tions) or with long-term complications (e.g. graft failure and recipient’s death) might add important insights to 
this area. Our recipients’ follow-up is limited to 1-year, and the incidence of graft failure and recipients’ death 
was low accordingly. Longer recipients’ and donors’ follow-ups are needed to examine the real impact of these 
variables on LKDs’ psychosocial  outcomes29.
Limitations. Data about the surgical techniques (open vs. laparoscopic nephrectomy) was not included in 
the statistical analysis and we may not be sure whether the inclusion of these variables would change the clusters’ 
structure. However, available literature suggests that differences in surgical techniques seem poorly related to 
HRQoL  outcomes39–42.
We cannot determine whether donors who completed only the pre-donation questionnaire (13.9%), avoided 
participating in the follow-up process due to the malfunctioning of psychosocial or physical nature. In our 
study, the completers were characterized by lower levels of depression and higher scores in personality extra-
version scale. Depression has been associated with poor adherence to self-care regimens and increased medi-
cal complications in patients with chronic medical  illness43. Also, adaptive personality characteristics such as 
high extroversion (the tendency to positive affect and interpersonal connection) has been found as the only 
personality characteristic significantly correlated with post-donation  growth44. Therefore, we may not discard a 
“self-selection” bias in our sample with donors with more resilient traits, being more likely to respond the post-
donation questionnaire. For this reason, these results need to be considered with some caution.
The follow-up sample size did not allow a segmented analysis by transplant center. Center-specific practices 
might compromise the generalization of our results (e.g. center policies to select donors with comorbidities and/
or countries regulations to limit donation by type of donor-recipient relationship). The inclusion of other centers 
might increase the number of participants to help solve this issue. Moreover, the limited sample size lowered the 
statistical power, especially in multivariate analysis.
We used as reference data for SF-36 T-scores the general population, which includes subjects with chronic 
diseases. As was suggested by previous authors, a comparison with a healthy population might be  preferable11. 
However, even a selected healthy cohort might not be adequate, because some LKDs may suffer from hyperten-
sion or metabolic disorders before the donation and a healthy population will not undergo a surgical intervention 
comparable to kidney  donation45.
The absence of the inclusion of a control group to clarify if the observed changes in LKDs psychosocial sphere 
also have occurred had they not donated, and if these changes do not differ from the changes observed in the 
general population as normal  fluctuations13.
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Our cluster 2 was characterized by shorter elapsed time from donation to post-assessment. This difference 
might be caused by the variability of each participant to answer the post-donation questionnaire (e.g. elapsed 
time for postal-mail reception or elapsed time between reception and donor completion). It is well recognized 
that LKDs HRQoL usually returns to baseline over time or remains slightly  reduced3, 30.
Kidney recipient variables were assessed only in medical terms, socio-demographic and psychosocial vari-
ables were not collected. Thus, it is not possible to determinate if the recipients’ psychosocial status (pre and 
post-transplantation) influenced their donors’ psychosocial outcome.
Conclusion
LKDs’ do well at 1-year follow-up and their HRQoL is comparable with the general population. However, after 
donation, a subgroup of donors characterized by feeling somewhat unsure about the surgery and their risks 
before donation and feeling emotionally involved and committed to ameliorating the suffering of their recipients, 
showed a worsening of their HRQoL, mainly due to the physical domain.
Methods
The study was approved by the Ethics Committee of the Hospital Clinic of Barcelona and by the Institutional 
Ethical Committees at each participant center. The investigation was performed according to the Declaration of 
Helsinki 2000. All donors provided written informed consent to participate.
Study design. We conducted a prospective, multicenter longitudinal study. The participating centers were: 
Hôpital Necker Enfants Malades (France), Charité Universitätsmedizin Berlin (Germany), Centro Hospitalar 
do Porto (Portugal), Hospital Clinic of Barcelona (Spain), and Sahlgrenska University Hospital (Sweden). The 
Turkish Medical Park Hospital Antalya contributed on the bibliography revision, and sharing their experiences 
as one of the largest transplant centers in Europe, performing up to 500 LKDTs per  year46.
Participants. LKDs who donated in the participating centers during the timeframe of the study were invited 
to participate; the inclusion period was 12 months (year 2011). LKDs were excluded if: (a) it was not possible to 
send back the questionnaire by postal-mail because the donor did not live in the transplant center’s country, (b) 
were illiterate, (c) did not understand the transplant country’s main language.
Instruments. The research team identified and get consensus about the most relevant variables along poten-
tial risk factors to be assessed during the donor evaluation.
The standardized psychometric instruments for the psychosocial assessment were chosen if a validated ver-
sion in every participant center’s language was available, if norms for the general population had been defined, 
and on the basis of their reputation and acceptance in the clinical and scientific society (supplementary table 1). 
The following domains and instruments were included in the study:
Quality of life (QoL) Anamnestic Comparative Self-Assessment (ACSA); 36-Item Short Form Survey (SF-36).
Mental health status Hospital Anxiety Depression Scale (HADS).
Coping strategies Dispositional Optimism (LOTR); Sense of Coherence scale (SOCS).
Personality Eysenck Personality Questionnaire-Revised-Abbreviated (EPQ-RA).
Socio-economic status English Longitudinal Study of Ageing (ELSA) Self-anchoring scale.
Considering that generic instruments might be unable to capture some of the subtleties of LKDT, specific ad 
hoc items regarding the donation process were extracted from previous  studies47–49, and/or were designed for 
each outcome area (e.g. motivation for donation, risk assessment, decision-making process) (supplementary 
annex 1). The methodology to translate the ad hoc items, was similar for all the centers. First, one independent 
translation from English to each participant language were obtained from professional translators, who were 
native English speakers and bilingual in the center language. Second, the research team of each participant center 
and the translator agreed on a version conceptually equivalent to the original one.
The recipients’ clinical profile and outcome was examined in order to assess its potential influence on LKDs 
psychological outcomes. We collected data on pre-transplantation clinical parameters (e.g. African ancestry, 
primary chronic kidney disease), risks factors (e.g. high immunological risk, comorbid diseases), and recipient/
graft 1-year complications (e.g. permanent kidney damage) (supplementary annex 2).
Procedure. To ensure a proper implementation of the methodology, each participant center applied the 
same questionnaires and adapted the methodology to their characteristics and own resources (e.g. the creation 
of multidisciplinary teams inside the hospitals with the involvement of a psychologist). LKDs questionnaires 
were self-administrated.
Pre-donation. Approximately 1-month before donation, potential LKDs were informed face-to-face about the 
study by the responsible investigator. At this stage, they signed the informed consent form and received a printed 
questionnaire to be completed at home before the psychological evaluation.
Post-donation. Approximately 12-months after donation, LKDs were contacted by phone in advance and asked 
whether they would agree to receive the post-operative questionnaire via postal-mail. They were asked to return 
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the questionnaire in a pre-paid envelope. LKDs that did not send the questionnaire back within a month were 
contacted again by phone.
The nephrologist responsible for the recipients’ care collected data regarding their clinical variables on stand-
ardized form (supplementary annex 2).
Data management. An online database was developed to introduce the data about the study. The partici-
pant centers were responsible to introduce in the database their own data provided from each of the question-
naires. All the items were coding to facilitate the subsequent importation and analysis of the data.
Statistical procedures. The factor structure of motivation for donation was assessed by principal compo-
nent analysis, retaining those factors above the point where the slope goes from steep to flat in the scree-plot 
(elbow point)50. The internal consistency of the items forming each derived factor was assessed by Cronbach’s 
alphas.
LKDs that completed follow-up and those lost during the follow-up were compared to ensure that the cause 
of attrition was not related to LKDs’ characteristics or to the characteristics of their recipient.
First assessment: means at pre and post-donation of quantitative variables (e.g. SF-36, and HADS) were 
compared by paired t-test. Categorical variables were compared by the McNemar test.
Second assessment: the potential grouping of LKDs according to their level of HRQoL was assessed with a 
two-step cluster-analysis using the percentage of change observed in the SF-36 T-scores. Against the traditional 
k-means and hierarchical clustering approaches, two-step cluster allows using variables with different measure-
ment levels or continuous with skewed distribution, and automatically determines the optimum number of 
 clusters51. Mean or proportion differences between clusters were analyzed to characterize those donors with a 
HRQoL decrement.
This clustering of LKDs’ outcomes allowed for the selection of potential predictive variables of HRQoL dec-
rement, which was done in two-steps: firstly, univariate logistic regression models with the group obtained in 
cluster-analysis as the dependent variable, and each of the potential risk factors as independent terms were esti-
mated. The false discovery rate was applied to know what predictors kept statistical significance after  correction52. 
Secondly, each predictor reaching a non-corrected statistical significance below 0.30 was selected as potential 
predictor for the next  analysis53. A logistic regression model with forward stepwise selection based on the signifi-
cance value was applied to obtain the final best predictive model of the clusters previously derived. The predic-
tive capability of the final model was assessed through the percentage of total correct classifications, sensibility, 
specificity, and the area under the ROC curve (AUC). Because the limited sample size did not allow to validate 
results by splitting the sample, an internal validation with bootstrapping calculation was done to obtain AUC 54.
Addendum. Previous publications have shown that the classical N/p rule-of-thumb does not perform very well 
in  practice55. A simulation paper has addressed requirements of exploratory factor analysis with small sample 
sizes (even lower than N = 50)56, indicating that other consideration as the factor’s correlations, the quantity of 
secondary loadings, the gap size between eigenvalues or the communalities are more important to warranty the 
stability of the estimations. In our data, a 19% of the items load in more than one factor (none in 3 or more fac-
tors). The rotated eigenvalues are close to each other as revealed by the explained percentage of variance (15.6%, 
14.2%, 12.4% and 11.5%), the communalities are quite homogeneous (range 0.23–0.77), and when estimating a 
non-orthogonal rotation allowing factors to correlate between them, the obtained correlations are low.
Data availability
The data that support the findings of this study are available on request from the corresponding author.
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